The Health Administration of Canada has warned against the use of malaria drugs, hydroxychloroquine and chloroquine, to combat or treat Covid-19 disease, days after France issued a similar warning.
The Canadian Health Administration said that these two drugs may cause serious side effects, including problems with the heartbeat.
She advised not to use these two drugs except on the prescription of a doctor.
This was preceded by the French Medicines Agency’s warning Saturday to doctors, against the use of hydroxychloroquine in the fight against Covid-19.
The National Agency for the Safety of Medicines and Health Products in France also issued a warning about the anti-malarial drug, which is also used to treat lupus and rheumatoid arthritis.
She reported that more than half of the 321 “unpleasant side effects” of treatments currently used for the emerging coronavirus are caused by the drug hydroxychloroquine and the anti-inflammatory drug azetromycin used with.
The agency announced that since the epidemic appeared, serious side effects were recorded in 80% of the reported cases.
On Thursday, the European Medicines Agency voiced its voice for concerns about the use of malaria drugs.
And the Amsterdam-based body stated that “recent studies have recorded serious problems with the heartbeat and in some cases fatal when using chloroquine or hydroxychloroquine, especially when used in high doses or alongside the anti-inflammatory azitromycin.”